Ubique
3 known investors
Find your way into Ubique
Ubique Biotech develops AI-designed synthetic reagents (antigen and antibody based) for precision diagnostics used in formats such as ELISA and rapid point-of-care tests. Founded in 2022, it focuses on affordable, scalable disease detection and screening without extensive laboratory infrastructure.
Investors · 3
In the news
Frequently asked questions
- What does Ubique do?
- Ubique Biotech develops AI-designed synthetic reagents (antigen and antibody based) for precision diagnostics used in formats such as ELISA and rapid point-of-care tests. Founded in 2022, it focuses on affordable, scalable disease detection and screening without extensive laboratory infrastructure.
- Who are Ubique's investors?
- Ubique's investors include GRIDX, Extreme Venture Partners, Innovacorp.